Literature DB >> 8182715

Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register.

R G Elles1, K A Hodgkinson, N P Mallick, D J O'Donoghue, A P Read, S Rimmer, E A Watters, R Harris.   

Abstract

Diagnosis of autosomal dominant adult polycystic kidney disease (APKD) is possible by ultrasonographic scanning (USS) or by using DNA markers linked to the PKD1 locus. Ultrasonography is complicated by the age dependent penetrance of the gene and linkage studies are subject to recombination errors owing to meiotic crossing over and locus heterogeneity. This study draws on data collected from a voluntary family register of APKD over 10 years. Records of 150 families were examined, ultrasound reports were obtained from 242 people at 50% prior risk, and 37 families were typed for DNA markers. The fraction of APKD resulting from loci unlinked to PKD1 (designated PKD2 here) was calculated at 2.94% (upper confidence limit 8.62%). Some subjects who were negative on initial scan later gave a positive scan, but there was no example of a definite gene carrier aged over 30 giving a negative scan. In families large enough for linkage analysis, most people who were at 50% prior risk could be given a final risk below 5% or above 95%, by using combined ultrasound and DNA studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182715      PMCID: PMC1049671          DOI: 10.1136/jmg.31.2.115

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  26 in total

1.  Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families.

Authors:  O Z DALGAARD
Journal:  Acta Med Scand Suppl       Date:  1957

2.  Genetic heterogeneity of polycystic kidney disease in Europe.

Authors:  D J Peters; L A Sandkuijl
Journal:  Contrib Nephrol       Date:  1992       Impact factor: 1.580

3.  Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16.

Authors:  A D Thompson; Y Shen; K Holman; G R Sutherland; D F Callen; R I Richards
Journal:  Genomics       Date:  1992-06       Impact factor: 5.736

4.  Regional localization of the autosomal dominant polycystic kidney disease locus.

Authors:  S T Reeders; T Keith; P Green; G G Germino; N J Barton; O J Lehmann; V A Brown; P Phipps; J Morgan; J C Bear
Journal:  Genomics       Date:  1988-08       Impact factor: 5.736

5.  Linkage heterogeneity of autosomal dominant polycystic kidney disease.

Authors:  W J Kimberling; P R Fain; J B Kenyon; D Goldgar; E Sujansky; P A Gabow
Journal:  N Engl J Med       Date:  1988-10-06       Impact factor: 91.245

6.  Prognosis of adult onset polycystic kidney disease re-evaluated.

Authors:  D N Churchill; J C Bear; J Morgan; R H Payne; P J McManamon; M H Gault
Journal:  Kidney Int       Date:  1984-08       Impact factor: 10.612

7.  Polycystic kidney disease re-evaluated: a population-based study.

Authors:  F Davies; G A Coles; P S Harper; A J Williams; C Evans; D Cochlin
Journal:  Q J Med       Date:  1991-06

8.  Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling.

Authors:  J C Bear; P McManamon; J Morgan; R H Payne; H Lewis; M H Gault; D N Churchill
Journal:  Am J Med Genet       Date:  1984-05

9.  Improved early diagnosis of adult polycystic kidney disease with flanking DNA markers.

Authors:  M H Breuning; S T Reeders; H Brunner; J W Ijdo; J J Saris; A Verwest; G J van Ommen; P L Pearson
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321

10.  A second genetic locus for autosomal dominant polycystic kidney disease.

Authors:  G Romeo; M Devoto; G Costa; L Roncuzzi; L Catizone; P Zucchelli; G G Germino; T Keith; D J Weatherall; S T Reeders
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

View more
  5 in total

Review 1.  An overview of clinical molecular genetics.

Authors:  R Elles
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

2.  The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).

Authors:  Kathy A Hodgkinson; Patrick S Parfrey; Anne S Bassett; Christine Kupprion; Jörg Drenckhahn; Mark W Norman; Ludwig Thierfelder; Susan N Stuckless; Elizabeth L Dicks; William J McKenna; Sean P Connors
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

3.  A non-synonymous mutation in the canine Pkd1 gene is associated with autosomal dominant polycystic kidney disease in Bull Terriers.

Authors:  Puya Gharahkhani; Caroline A O'Leary; Myat Kyaw-Tanner; Richard A Sturm; David L Duffy
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

4.  International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people.

Authors:  Charlotte Gimpel; Carsten Bergmann; Detlef Bockenhauer; Luc Breysem; Melissa A Cadnapaphornchai; Metin Cetiner; Jan Dudley; Francesco Emma; Martin Konrad; Tess Harris; Peter C Harris; Jens König; Max C Liebau; Matko Marlais; Djalila Mekahli; Alison M Metcalfe; Jun Oh; Ronald D Perrone; Manish D Sinha; Andrea Titieni; Roser Torra; Stefanie Weber; Paul J D Winyard; Franz Schaefer
Journal:  Nat Rev Nephrol       Date:  2019-11       Impact factor: 28.314

5.  Developments in the management of autosomal dominant polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Mir Reza Bekheirnia; Robert W Schrier
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.